Medical Device Price and Valuation

Silvie Jerabkova ()
Additional contact information
Silvie Jerabkova: University of Economics

Chapter Chapter 76 in New Trends in Finance and Accounting, 2017, pp 823-829 from Springer

Abstract: Abstract This paper deals with disunity in approaches towards what should be considered an adequate price of a medical device, what are its components and above all, how should a medical device be valued. Such a valuation is crucial for designing medical care reimbursement schemes, for health technology assessment (HTA) calculations and also for innovative medical device producers’ investment decisions. The present paper analyses the components of medical device prices and presents some medical device valuation and pricing methods. Reimbursement and early-stage decisions involving the Bayesian prior are covered. Options valuation method and pay-for-performance are described. Specificities of the medical device market and industry are closely examined. Revenue-oriented method is put forward as a possible way of medical device valuation.

Keywords: Medical device; Price; Valuation; Health technology assessment (HTA) (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:prbchp:978-3-319-49559-0_76

Ordering information: This item can be ordered from
http://www.springer.com/9783319495590

DOI: 10.1007/978-3-319-49559-0_76

Access Statistics for this chapter

More chapters in Springer Proceedings in Business and Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().